Abbott Laboratories
BMV:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
BMV:ABT
|
US |
|
L
|
Life Healthcare Group Holdings Ltd
XBER:L53
|
ZA |
|
D
|
Danakali Ltd
XBER:SO3
|
AU |
|
A
|
AVEVA Group PLC
XBER:4A91
|
UK |
|
V
|
Vale Indonesia Tbk PT
XBER:XT3B
|
ID |
|
Huatai Securities Co Ltd
F:206H
|
CN |
|
Nicox SA
F:NXOA
|
FR |
|
H
|
Henkel AG & Co KGaA
XMUN:HEN
|
DE |
|
Fabasoft AG
F:FAA
|
AT |
|
OC Oerlikon Corporation AG Pfaeffikon
OTC:OERLY
|
CH |
|
A
|
Alstom SA
XMUN:AOMD
|
FR |
|
Abeo SA
PAR:ABEO
|
FR |
|
Kirin Holdings Co Ltd
OTC:KNBWY
|
JP |
|
Euro Sun Mining Inc
TSX:ESM
|
CA |
|
A
|
Adidas AG
DUS:ADS
|
DE |
|
E
|
Entain PLC
SWB:6GI
|
IM |
|
H
|
Hargreaves Lansdown PLC
F:DMB
|
UK |
|
I
|
Insulet Corp
XMUN:GOV
|
US |
|
W
|
Westpac Banking Corp
F:WBC
|
AU |
|
Hummingbird Resources PLC
LSE:HUM
|
UK |
|
W
|
Westpac Banking Corp
SWB:WBC
|
AU |
|
J
|
Juniper Networks Inc
F:JNP
|
US |
Wall St Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABT is 2 136.33 MXN with a low forecast of 1 653.74 MXN and a high forecast of 2 541.47 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
2 136.33
MXN
According to Wall Street analysts, the average 1-year price target for ABT is 2 136.33 MXN with a low forecast of 1 653.74 MXN and a high forecast of 2 541.47 MXN.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 17%.
